Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-031685
Filing Date
2016-05-12
Accepted
2016-05-12 16:33:37
Documents
70
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20160330_10q.htm 10-Q 993706
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10407
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10141
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5140
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5433
  Complete submission text file 0001437749-16-031685.txt   5342396

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS nby-20160331.xml EX-101.INS 997802
7 EXHIBIT 101.SCH nby-20160331.xsd EX-101.SCH 61436
8 EXHIBIT 101.CAL nby-20160331_cal.xml EX-101.CAL 34416
9 EXHIBIT 101.DEF nby-20160331_def.xml EX-101.DEF 423260
10 EXHIBIT 101.LAB nby-20160331_lab.xml EX-101.LAB 350181
11 EXHIBIT 101.PRE nby-20160331_pre.xml EX-101.PRE 444424
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 161644439
SIC: 2834 Pharmaceutical Preparations